- Home
- SYBX
SYBX
Synlogic Inc.
as of 12-04-2025 2:53pm EST
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | WINCHESTER |
| Market Cap: | 15.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 32.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.90 - $1.96 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | -99.76% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered SYBX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Synlogic Inc. (SYBX)
See Remarks below
Avg Cost/Share
$1.81
Shares
157
Total Value
$284.17
Owned After
12,744
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dooley Mary Beth | SYBX | See Remarks below | Oct 29, 2025 | Sell | $1.81 | 157 | $284.17 | 12,744 |
Compare SYBX vs Leading Stocks
See how SYBX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SYBX Synlogic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.